Orange Book product · Generic (ANDA)
KANAMYCIN SULFATE
KANAMYCIN SULFATE
At a glance
Dec 17, 2002
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 17, 2002
23 yr 10 mo ago
Today
Pharmaceutical detail
Active ingredient
KANAMYCIN SULFATE
Strength
EQ 1GM BASE/3ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
ANDA 065111
Product number
002
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of KANAMYCIN SULFATE
- 1992KANAMYCIN SULFATEGeneric (ANDA)
ANDA 063025 · LOCH
- 1992KANAMYCIN SULFATEGeneric (ANDA)
ANDA 063021 · LOCH
- 1992KANAMYCIN SULFATEGeneric (ANDA)
ANDA 063022 · LOCH
- 1989KANAMYCIN SULFATEGeneric (ANDA)
ANDA 063092 · WARNER CHILCOTT
- 1987KANAMYCIN SULFATEGeneric (ANDA)
ANDA 062669 · PHARMAFAIR
- 1987KANAMYCIN SULFATEGeneric (ANDA)
ANDA 062668 · PHARMAFAIR
- 1987KANAMYCIN SULFATEGeneric (ANDA)
ANDA 062672 · PHARMAFAIR
- 1987KANTREXGeneric (ANDA)
ANDA 062726 · APOTHECON
- 1986KANAMYCIN SULFATEGeneric (ANDA)
ANDA 062605 · SOLOPAK
- 1985KANAMYCIN SULFATEGeneric (ANDA)
ANDA 062520 · WATSON LABS
- 1984KANTREXGeneric (ANDA)
ANDA 062564 · APOTHECON
- 1984KANAMYCIN SULFATEGeneric (ANDA)
ANDA 062504 · ABRAXIS PHARM
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
